Search results for "Cannabinoid receptor binding"

showing 1 items of 1 documents

A novel peripherally restricted cannabinoid receptor antagonist, AM6545, reduces food intake and body weight, but does not cause malaise, in rodents

2010

BACKGROUND AND PURPOSE Cannabinoid CB1 receptor antagonists reduce food intake and body weight, but clinical use in humans is limited by effects on the CNS. We have evaluated a novel cannabinoid antagonist (AM6545) designed to have limited CNS penetration, to see if it would inhibit food intake in rodents, without aversive effects. EXPERIMENTAL APPROACH Cannabinoid receptor binding studies, cAMP assays, brain penetration studies and gastrointestinal motility studies were carried out to assess the activity profile of AM6545. The potential for AM6545 to induce malaise in rats and the actions of AM6545 on food intake and body weight were also investigated. KEY RESULTS AM6545 binds to CB1 recep…

PharmacologyAM251medicine.medical_specialtyCannabinoid receptormedicine.medical_treatmentAntagonistPharmacologyBiologyEndocrinologyInternal medicinemedicineCannabinoid receptor bindingCannabinoid receptor type 2Cannabinoid receptor antagonistlipids (amino acids peptides and proteins)CannabinoidReceptormedicine.drugBritish Journal of Pharmacology
researchProduct